Category Archives: News

RECALL NOTICE

Abbott is initiating a proactive, voluntary recall of powder formulas, including Similac®, Alimentum® and EleCare® manufactured in Sturgis, Mich., one of the company’s manufacturing facilities. Check a multidigit number on the bottom of the container to know if your product is included:
The first two digits of the code are 22 through 37; and
The code on the container contains K8, SH or Z2; and
The expiration date is 4-1-2022 (APR 2022) or later. Click here for more info – https://www.similacrecall.com/us/en/home.html

Essential Worker Day

Iona College is honoring essential workers on February 20 at the men’s basketball home game vs Fairfield University! 🏀 Dubbing it “Essential Worker Day,” Iona is giving a special thank you to those who have bravely served both prior and throughout the COVID-19 pandemic, by providing complimentary tickets to the game and one free t-shirt for all essential workers in attendance. Essential workers can redeem their complimentary tickets online with the code HERO22 Get your tickets now! iona.edu/tix

COVID Vaccination for children 5-11 years of age

Exciting news!  The FDA and CDC approved Pfizer COVID vaccination for 5-11 year olds as of November 2nd, under Emergency Use Authorization.  This vaccine is 1/3 the dose given to adolescents and adults.    The vaccine will be given as 2 doses separated by 21 days.  There are few contradictions to the vaccine including history of allergies to any of the components of the vaccine.  The vaccine is currently available at several Yale New Haven Health Services locations including Greenwich Hospital.  Please schedule your child’s vaccination via the link below:

https://covidvaccine.ynhh.org

Children’s Medical Group has applied for in-office distribution of the vaccine.  Unfortunately, we do not yet know when we will be receiving the vaccine in our office.  We will send out another email blast and update the website as soon as we are able to schedule your child’s vaccination.

Children’s Medical Group recommends COVID vaccination to prevent COVID infections, long-term COVID complications, hospitalizations, and potential fatalities.  Vaccinations also decrease school disruptions and is an important step toward addressing the mental health crisis we are now seeing in our pediatric patients.  Vaccination is critical to ending the COVID pandemic.

The following articles will answer most of your COVID vaccine questions.  If you have additional questions regarding the vaccine, you may contact our office via phone or the patient portal.

https://publications.aap.org/aapnews/news/17751

https://www.npr.org/sections/health-shots/2021/11/03/1051299050/covid-vaccine-kids-5-11

https://www.usatoday.com/story/news/health/2021/11/01/covid-vaccine-children-kids-approval/8564341002/

A letter from Dr. Cody

To all my families at CMG,

Let me start by saying it was a true honor and privilege to take care of you and your children for the last 34 years. I have watched many of you grow and have even had the pleasure of taking care of your children!

That is why this decision did not come easily.

It is with a heavy heart that I announce that I will not be returning to Children’s Medical Group. The pandemic has affected us all and continues to affect us. Having an underlying heart issue has kept me away from all of you over the last 18 months on a medical leave with my doctor’s guidance. During my time at home I have been able to work on a parenting book and also write some poetry!

One poem has even been published! Stay posted!

I look forward to the next chapter in my life but I will truly miss all of you!

Please keep in touch!
lorettar22@aol.com

Wishing you all the best!

Loretta Cody

Controlled substance prescriptions

For our patients who require controlled substance prescriptions:
Please give one weeks notice if you need a refill because it must be prescribed by your child’s primary physician (who may or may not be available on the day of your request)
Also, the state requires a consultation appointment, with your primary doctor, every 4 months in order to continue prescribing controlled substances.

Adolescent opioid use

In light of the growing adolescent opioid use problem in the United states, we would like to share the latest policy statement issued by the American Academy of Pediatrics.

AAP: Offer Teens Medication-Assisted Tx for Opioid Addiction
Treatment underused, severely restricted for young patients
Medication-assisted treatment should be offered to adolescents with severe opioid use disorders, said the American Academy of Pediatrics in a new policy statement.
Characterizing medication-assisted treatment in adolescents as “underused” and “severely restricted,” the AAP called upon pediatricians to offer this type of care to their patients with opioid use disorders or to refer patients to other health professionals who may provide this service, reported the AAP Committee on Substance Use and Prevention in Pediatrics.

Buprenorphine, naltrexone and methadone are the three medications currently indicated to treat opioid use disorder, though the authors noted there is limited research on their effect on adolescents. Buprenorphine was approved for use in patients ages 16 years and older, and two randomized trials found that adolescents and young adults taking the medication were more likely to continue medical care and had lower rates of illicit opioid use.
Despite “promising” anecdotal reports, the authors wrote that naltrexone lacks “rigorous research support” that it is effective in adolescents. They added that the medication also reduces alcohol cravings, making it a potentially good option for young people who also have an alcohol use disorder.
While methadone is indicated for treating opioid use disorder, federal regulations prohibit most methadone treatment programs from admitting children under 18 years old.
The authors also encouraged improved access to medication-assisted treatment, such as community-based substance disorder counseling, for these adolescents. Further research into other “developmentally appropriate treatment” was recommended for this population, including primary and secondary prevention and behavioral interventions.
“The time to act is now to take advantage of these medications that can have a profound impact of the lives of adolescents and young adults struggling with opioid addiction,” said Michael Weaver, MD, of McGovern Medical School at UTHealth in Houston, who was not involved with the statement. “The epidemic of opioid addiction in the U.S. has disproportionately affected adolescents and young adults, and multiple medications are available that can save lives.”

“These medications are not being used in a majority of programs, even though they are evidence-based and standard of care,” said Weaver. “Pediatricians can take the initiative and prescribe naltrexone to appropriate patients right away with no need for specialized training, or prescribe buprenorphine after completing an 8-hour training program available through AAP.”
In fact, one study found that less than half of addiction treatment programs for both adolescents and adults offer medication treatment programs, and only about a third of opioid-dependent patients receive medication treatment (compared with 70% of patients with mental health disorders).
“Policies, attitudes, and messages that serve to prevent patients from accessing a medication that can effectively treat a life-threatening condition may be harmful to adolescent health,” the authors wrote.
LAST UPDATED 08.22.2016
Primary Source
Pediatrics
Source Reference: Committee on Substance Use and Prevention “Medication-assisted treatment of adolescents with opioid use disorders” Pediatrics 2016; DOI: 10.1542/peds.2016-1893.

Source http://www.medpagetoday.com/psychiatry/addictions/59802

MENINGITIS B

Children’s Medical Group is now recommending that our patients, age 16-23, get vaccinated against meningococcal group B disease. also known as meningitis B. We are recommending the vaccine for those entering college and those already enrolled.

Until 2014, there were no vaccines to help protect against meningitis B in the US. In 2015, outbreaks of meningitis B occurred on several college campuses. Trumenba, a 2 dose vaccine, administered 6 months apart, can help protect your child from this uncommon, but potentially deadly disease. Even though your child may have received a meningitis vaccine (Menactra) already, the previous vaccine did not protect against meningitis B. Both vaccines are necessary for thorough coverage.

Please click on this document for more information from the CDC.

Call our office, 203-661-2440, to schedule your child’s appointment.